Kirsten G F, Steyn D W, Muller L, Geerts L, Riphagen S, de Beer R, Kriel J, Smith J, Odendaal H J
Department of Paediatrics, MRC Perinatal Mortality Research Unit, Tygerberg, W. Cape.
S Afr Med J. 1995 Oct;85(10 Suppl):1091-6.
To determine the outcome of babies of mothers with severe rhesus (Rh) incompatibility treated by elective delivery when the amniotic optical density at 450 nm crossed Whitfield's action line (group 1), by plasmapheresis and immunotherapy (group 2) or by means of intra-uterine intravascular transfusions (group 3).
A retrospective study of 55 mothers and their 57 fetuses with severe Rh incompatibility at < 34 weeks' pregnancy duration.
Number of mothers in each treatment group, prevalence of intra-uterine death, hydrops, intra-uterine intravascular transfusions, cord haematocrit, cord bilirubin, number of liveborn babies, birth weight, neonatal death, hyaline membrane disease (HMD) and exchange transfusions.
All mothers and babies with severe Rh incompatibility (defined as an amniotic optical density of 450 nm in the upper and upper-mid zone on the Liley chart at < 34 weeks' pregnancy duration, previous fetal hydrops or Rh-related intra-uterine death (IUD), fetal hydrops on ultrasound or a fetal haematocrit < 30% at cordocentesis) treated at Tygerberg Hospital between January 1980 and January 1993. There were 20 fetuses each in groups 1 and 3, and 17 in group 2.
A total of 48 babies (84%) were liveborn and of these 74% survived the neonatal period. (ABSTRACT TRUNCATED AT 250 WORDS)
确定孕期小于34周、母亲患有严重恒河猴(Rh)血型不合的婴儿,在羊水450nm处光密度超过惠特菲尔德作用线时接受择期分娩(第1组)、血浆置换和免疫治疗(第2组)或宫内血管内输血(第3组)后的结局。
对55名母亲及其57名孕期小于34周的患有严重Rh血型不合的胎儿进行回顾性研究。
各治疗组母亲的数量、宫内死亡、水肿、宫内血管内输血、脐血细胞比容、脐胆红素、活产婴儿数量、出生体重、新生儿死亡、透明膜病(HMD)和换血治疗的发生率。
1980年1月至1993年1月在泰格堡医院接受治疗的所有患有严重Rh血型不合的母亲和婴儿(定义为孕期小于34周时,利利图表上羊水450nm处光密度处于上区和中上区、既往有胎儿水肿或Rh相关的宫内死亡(IUD)、超声检查发现胎儿水肿或脐静脉穿刺时胎儿血细胞比容小于30%)。第1组和第3组各有20例胎儿,第2组有17例。
共有48名婴儿(84%)活产,其中74%存活至新生儿期。(摘要截短至250字)